A policy analysis from Australia found that zero-tolerance THC driving laws disproportionately harm medicinal cannabis patients, whose road safety risks appear similar to or lower than those taking other legal prescription medications that impair driving.
Medicinal cannabis patients concerned about driving laws, policymakers working on drug driving legislation, and anyone interested in the tensions between cannabis health and traffic policy.
Road risk similar to other prescription drugs
What the researchers found
Road safety risks associated with medicinal cannabis appear similar to or lower than numerous other potentially impairing prescription medications. Zero-tolerance THC laws criminalize patients who test positive for THC even when not impaired and using cannabis as prescribed. Some patients forgo needed medication to maintain driving access, while others face criminal sanctions despite following medical advice.
Why it matters
As countries legalize medical cannabis but maintain zero-tolerance driving laws based on THC detection (not impairment), patients face a cruel choice between medication and mobility. This analysis argues the inconsistency is rooted in cannabis's historical prohibition, not evidence.
The numbers in context
Medical exemptions exist for other impairing drugs like methadone in Australia; THC presence-based offences apply regardless of impairment; comparable jurisdictions have implemented medical exemptions for cannabis
How the study worked
Policy analysis examining Australian regulatory approaches to potentially impairing prescription drugs versus illicit drugs, evidence on cannabis and road safety risk, patient impact data, and international comparisons of medicinal cannabis driving regulations.
What this study cannot tell us
Focused on Australian policy context. Does not provide new empirical data on driving impairment. Arguments rely on existing evidence base, which has limitations around cannabis and driving.
How to read the evidence
Policy analysis synthesizing existing evidence. Arguments are well-supported but this is not a systematic review of driving impairment data.
When this study was published
Published in 2021; several jurisdictions have since updated their medicinal cannabis driving laws.
The bigger picture
The tension between health policy (approving cannabis as medicine) and traffic policy (criminalizing any THC presence) creates an incoherent legal landscape. Other jurisdictions have resolved this through medical exemptions, demonstrating feasible alternatives to the Australian approach.
Questions still open
- What level of THC correlates with meaningful driving impairment in regular medical users? How do tolerance effects change the risk profile for daily medicinal cannabis patients? Would impairment-based testing be more effective and equitable than presence-based testing?
Common questions
Can medicinal cannabis patients drive?
Is medicinal cannabis more dangerous for driving than other medications?
Read the original research
Medicinal cannabis and driving: the intersection of health and road safety policy.
The International journal on drug policy, 97, 103307
Citation
Perkins, Daniel; Brophy, Hugh; McGregor, Iain S; O'Brien, Paula; Quilter, Julia; McNamara, Luke; Sarris, Jerome; Stevenson, Mark; Gleeson, Penny; Sinclair, Justin; Dietze, Paul. (2021). Medicinal cannabis and driving: the intersection of health and road safety policy.. The International journal on drug policy, 97, 103307. https://doi.org/10.1016/j.drugpo.2021.103307